The Chinese equity markets displayed a classic pattern of 'high-opening, low-closing' volatility during the morning session on April 7, 2026. The tech-heavy ChiNext Index, which had initially surged by more than 1%, surrendered its gains to end the half-day session down 0.46%. This reversal underscores a persistent fragility in investor sentiment, even as trading volumes remain robust at over 1 trillion RMB.
While major indices struggled to find a floor, the chemical sector emerged as a significant outlier. Over a dozen stocks in the sector hit their daily price ceilings, driven by a surge in demand for organic silicon and large-scale refining products. This movement suggests a strategic rotation by institutional investors toward industrial fundamentals and materials that support China's broader manufacturing ecosystem.
Technological self-reliance remains a potent narrative on the trading floor. Despite the broader market's cooling, the computing chip and Printed Circuit Board (PCB) sectors showed resilience. Cambricon, a key player in China's AI chip landscape, saw its shares jump by over 10%. This reflects continued speculative interest in the 'AI plus' theme, even as other growth sectors like innovative drugs faced sharp sell-offs.
Conversely, traditional heavyweights in the insurance and pharmaceutical sectors acted as a drag on the indices. Major insurers such as China Pacific Insurance and China Life saw steady declines, signaling a cautious outlook on the financial services sector. The sharp drop in 'innovative drug' stocks further highlights a market that is increasingly selective, favoring immediate industrial utility over long-term, high-risk R&D plays.